We are live on ! Find out more
EWM

Essex Woodlands Management Portfolio holdings

AUM $254M
1-Year Est. Return 4.59%
This Fund
S&P 500
This Quarter Est. Return
+46.34%
1 Year Est. Return
+4.59%
3 Year Est. Return
+54.96%
5 Year Est. Return
+25.37%
10 Year Est. Return
+254.56%
AUM
$504M
AUM Growth
+$184M
Cap. Flow
+$49.2M
Cap. Flow %
9.76%
Top 10 Hldgs %
100%
Holding
11
New
1
Increased
Reduced
1
Closed
4

Top Buys

Rank Stock Value
1
ENTL
Entellus Medical, Inc. Common Stock
ENTL
+$82.3M

Sector Composition

Rank Sector Weight
1 Healthcare 94.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABMD
1
DELISTED
Abiomed Inc
ABMD
$225M 44.73%
3,150,000
RVNC
2
DELISTED
Revance Therapeutics, Inc.
RVNC
$95.2M 18.88%
4,592,047
ENTL
3
DELISTED
Entellus Medical, Inc. Common Stock
ENTL
$83.5M 16.57%
+3,813,196
New +$82.3M
CORI
4
DELISTED
Corium International, Inc.
CORI
$61.3M 12.15%
9,353,304
ELGX
5
DELISTED
Endologix Inc
ELGX
$26.8M 5.32%
125,747
-125,747
-50% -$19.1M
ACUR
6
DELISTED
Acura Pharmaceuticals
ACUR
$7.73M 1.53%
2,056,977
MNOV icon
7
MediciNova
MNOV
$65M
$4.1M 0.81%
1,170,370
CRIS icon
8
Curis
CRIS
$4.5M
-117
Closed -$350K
PTN
9
Palatin Technologies
PTN
$13.2M
-19
Closed -$17K
TCRT icon
10
Alaunos Therapeutics
TCRT
$4.81M
-18,003
Closed -$13.7M
ECTE
11
DELISTED
ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE)
ECTE
-12,319
Closed -$17K

Similar funds

Essex Woodlands Management's Q1 2015 Portfolio in Review

As of Q1 2015, Essex Woodlands Management held 11 positions worth $504M, up 57% from $320M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Essex Woodlands Management deployed $49.2M of net new capital in Q1 2015, opening 1 new position. Its largest new stake was Entellus Medical, Inc. Common Stock: 3,813,196 shares worth $83.5M.

By sector, the portfolio is most concentrated in Healthcare at 95% of assets, up from 86% a quarter earlier.

On the sell side, the largest reduction was Endologix Inc, an estimated $19.1M trimmed.

  • Essex Woodlands Management's largest Q1 2015 buy was Entellus Medical, Inc. Common Stock: 3,813,196 shares worth $83.5M.
  • Essex Woodlands Management's biggest Q1 2015 reduction was Endologix Inc, cutting an estimated $19.1M.
  • Essex Woodlands Management fully exited Alaunos Therapeutics in Q1 2015, selling an estimated $13.7M.
  • Essex Woodlands Management's ten largest holdings make up 100% of its $504M portfolio in Q1 2015.
  • Essex Woodlands Management opened 1 new position and closed 4 in Q1 2015.
  • Essex Woodlands Management's portfolio value rose 57% quarter-over-quarter to $504M.

Based on Essex Woodlands Management's 13F filing for Q1 2015, filed 8 May 2015.